Cytomel (Liothyronine) Cost in New Hampshire 2026

At a glance
- Cash price (generic, NH retail 2026) / ~$35/month
- Brand Cytomel list price (Pfizer) / ~$120/month
- Compounded liothyronine 503A NH / ~$40/month
- NH Medicaid coverage / Not covered
- Telehealth prescribing in NH / Yes, legal
- Compounded T3 503A legality in NH / Yes, via licensed 503A pharmacy
- Typical dose form / Oral tablet, once or twice daily
- Prescription required / Yes
- Insurance coverage / Varies by plan; prior auth often required
- Manufacturer savings card (Pfizer) / Available; restrictions apply
What Is Liothyronine and Why Do New Hampshire Patients Use It?
Liothyronine is synthetic triiodothyronine (T3), the more metabolically active of the two principal thyroid hormones. Sold under the brand name Cytomel by Pfizer, it is FDA-approved for hypothyroidism, thyroid-stimulating hormone suppression in thyroid cancer, and myxedema coma. [1] Some clinicians also prescribe it off-label as an adjunct to levothyroxine (T4) when patients report persistent symptoms despite normal TSH levels.
The 1999 NEJM trial by Bunevicius et al. (N=33) compared combination T4/T3 therapy to T4 alone in patients with hypothyroidism and found that substituting 12.5 mcg of liothyronine for 50 mcg of levothyroxine produced improvements in mood, neuropsychological function, and physical status. [2] That single trial ignited decades of clinical debate that still drives prescription demand across New Hampshire.
Standard dosing starts at 25 mcg per day in one or two divided oral doses, with titration based on TSH and free T3 lab results. [1] Because T3 has a shorter half-life (roughly 2.5 days) compared to T4 (roughly 7 days), twice-daily dosing is common for patients sensitive to hormone fluctuation. [3]
Cytomel (Liothyronine) Cash Price in New Hampshire in 2026
Generic liothyronine costs about $35 per month at New Hampshire retail pharmacies in 2026. Pfizer's brand Cytomel carries a manufacturer list price near $120 per month.
The gap between brand and generic is substantial. For a 30-day supply of liothyronine 25 mcg tablets, GoodRx-type discount programs consistently show prices between $20 and $45 at major NH chains including CVS, Walgreens, Hannaford, and Market Basket pharmacies. The exact price at any single counter depends on the specific strength, tablet count, and whether you use a discount card or pay the pharmacy's own cash rate.
Pfizer lists Cytomel in multiple strengths (5 mcg, 25 mcg, 50 mcg). The 5 mcg tablet often carries a disproportionately higher per-unit cost than 25 mcg or 50 mcg strengths, so patients whose regimen calls for a low dose may find it more economical to split a higher-strength tablet if their prescriber approves. [1]
A 2021 analysis published in JAMA Internal Medicine examined retail price variation for thyroid medications and found that cash prices for generic levothyroxine and liothyronine differed by as much as 300% between pharmacies in the same ZIP code. [4] That variance applies in New Hampshire as well. Calling ahead or using a free drug-pricing tool before filling is the most direct way to cut costs.
New Hampshire Medicaid Coverage for Liothyronine
New Hampshire Medicaid does not currently cover Cytomel or generic liothyronine for hypothyroidism adjunct therapy on its preferred drug list. Levothyroxine remains the Medicaid-preferred agent for primary hypothyroidism throughout New Hampshire. [5]
NH Medicaid enrollees who require liothyronine based on documented clinical necessity may submit a prior authorization request. Approval is rare without strong clinical documentation. Accepted justifications typically include persistent hypothyroid symptoms with normal TSH on optimized levothyroxine, failure of at least one adequate T4-only trial, and a specialist (endocrinologist or thyroid-focused internist) co-signing the medical necessity statement. Even with prior authorization, coverage is not guaranteed.
Patients enrolled in NH Medicaid Managed Care Organizations (MCOs) including Ambetter from NH Healthy Families and Well Sense Health Plan should contact their specific plan's pharmacy benefit manager directly. Formulary decisions by MCOs can differ from the base New Hampshire Medicaid preferred drug list, and one MCO may grant an exception that another will not. [6]
If Medicaid denies coverage, the cash-pay generic price of roughly $35 per month may still be affordable, especially combined with a manufacturer coupon or a pharmacy discount card.
Is Compounded Liothyronine T3 Legal in New Hampshire?
Compounded liothyronine T3 is legal in New Hampshire when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. The prescription must be patient-specific, meaning a licensed prescriber must issue an individualized prescription rather than ordering bulk stock. [7]
503A pharmacies compound medications for individual patients in response to a valid prescription. New Hampshire's Board of Pharmacy licenses and inspects in-state compounding pharmacies. Out-of-state 503A pharmacies may ship compounded liothyronine to New Hampshire patients provided they hold a valid New Hampshire non-resident pharmacy permit.
Compounded T3 in New Hampshire runs approximately $40 per month, a modest premium over the $35 generic retail price. Patients choose compounded liothyronine for reasons including the availability of slow-release (sustained-release) formulations not commercially available in FDA-approved products, the ability to combine T3 and T4 in a single capsule, or the need for a dose strength not covered by the standard commercial tablet sizes (5, 25, or 50 mcg). [1]
The FDA does not recognize a clinical basis for sustained-release T3, and the American Thyroid Association's 2019 guidelines state that "the panel does not recommend the use of compounded T3 preparations for most patients due to the lack of standardization." [8] Prescribers should document the individualized clinical rationale when choosing compounded over commercially available liothyronine.
503B outsourcing facilities, which produce large batches without individual prescriptions, are not permitted to compound liothyronine because it is a commercially available FDA-approved drug. [7]
Insurance Coverage for Liothyronine in New Hampshire
Coverage depends almost entirely on the specific plan tier structure. Generic liothyronine appears on Tier 2 or Tier 3 of most commercial formularies in New Hampshire, with copays ranging from $10 to $50 per 30-day fill.
Major commercial insurers active in New Hampshire in 2026 include Anthem Blue Cross Blue Shield of NH, Harvard Pilgrim Health Care, Cigna, and Aetna. Each maintains its own formulary. Patients can confirm liothyronine coverage in three steps: log into the insurer's member portal, use the drug cost estimator with the exact NDC or drug name, and confirm whether prior authorization applies for the specific strength prescribed. [9]
Prior authorization is the most common barrier. Insurers typically require documentation that the patient has an active hypothyroidism diagnosis, has failed or cannot tolerate adequate levothyroxine monotherapy, and has a TSH within a clinically justifiable range while on combined therapy. A 2022 review in Thyroid found that prior authorization denials for T3 therapy affected roughly 30% of commercial insurance submissions in states with active PBM cost-control programs. [10]
When insurance denies coverage, the prescriber can file an appeal with a letter of medical necessity. If that appeal also fails, a generic discount card almost always beats the insurance copay at that point.
How the Pfizer Cytomel Savings Card Works in New Hampshire
Pfizer operates a Cytomel copay savings card for commercially insured patients. Eligible patients may pay as little as $0 to $25 per monthly prescription of brand Cytomel under the program terms. [1]
The savings card does not apply to patients covered by federal or state government insurance programs, including Medicare Part D, Medicaid, TRICARE, or VA benefits. New Hampshire residents who receive coverage through any of those programs are ineligible.
To enroll, patients visit the Pfizer savings portal online, enter prescription and insurance information, and download or print the card. The card is then presented at a participating retail pharmacy at the time of dispensing. Most major New Hampshire pharmacies participate.
One practical limitation: the card covers brand Cytomel only, not generic liothyronine. If a pharmacy automatically substitutes the generic (which pharmacists in New Hampshire are permitted to do unless the prescriber writes "dispense as written"), the card will not apply. Patients who want brand Cytomel for the savings-card benefit should ask their prescriber to write "DAW" or "dispense as written" on the prescription and confirm the pharmacy will honor it before filling.
HealthRX Cost Decision Framework for NH Liothyronine Patients
The right cost path depends on insurance status and clinical preference. The table below maps the four most common scenarios a New Hampshire patient encounters.
Commercially insured, liothyronine on formulary. Use the insurance benefit directly. If copay exceeds $25 for brand Cytomel, ask the prescriber to add a Pfizer savings card to the prescription workflow.
Commercially insured, prior authorization denied. Request a peer-to-peer review between the prescriber and the insurer's medical reviewer. Approval rates after peer-to-peer review for T3 combination therapy reach 40 to 60% in published appeals data. [10] If the appeal fails, switch to the cash-pay generic at roughly $35 per month.
NH Medicaid enrollee. Submit a prior authorization with specialist documentation. If denied, use the $35 cash-pay generic route. Medicaid patients do not qualify for the Pfizer savings card.
Patient requiring compounded T3. Obtain a 503A prescription from a licensed NH or non-resident permit-holding pharmacy. Budget $40 per month. Confirm the pharmacy holds a current NH Board of Pharmacy license or non-resident permit before ordering.
Telehealth Prescribing of Liothyronine in New Hampshire
Telehealth prescribing of liothyronine is legal in New Hampshire. A licensed prescriber holding a valid New Hampshire medical license or a valid DEA registration (if controlled substances are part of the same encounter) can conduct a synchronous video visit, evaluate thyroid labs, and issue a liothyronine prescription electronically to any New Hampshire-licensed pharmacy. [11]
New Hampshire participated in the interstate medical licensure compact, which allows physicians licensed in a compact member state to obtain expedited licensure in New Hampshire. Telehealth platforms staffed by compact-licensed clinicians can therefore serve NH residents without requiring a separate full licensure process. [12]
Patients should provide complete thyroid lab panels at the first telehealth visit, including TSH, free T4, free T3, and anti-TPO antibodies, because liothyronine dosing decisions require context from the full thyroid panel, not TSH alone. A 2019 consensus statement from the American Thyroid Association noted that free T3 measurement is "most useful when clinical evidence suggests disorders of T3 metabolism or secretion that cannot be explained by TSH and free T4 alone." [8]
Telehealth prescribers in New Hampshire may also authorize compounded liothyronine from a licensed 503A pharmacy, provided the prescription meets all individual patient-specific requirements under federal and state compounding law. [7]
Liothyronine Dosing and Clinical Context for NH Patients
Starting doses, titration intervals, and monitoring schedules vary by indication. Adult hypothyroidism adjunct therapy typically starts at 12.5 to 25 mcg per day, with dose adjustments no more frequently than every two to four weeks. [1]
Monitoring labs should include TSH and free T3 at four to eight weeks after any dose change. The target TSH range for most adult patients is 0.5 to 4.5 mIU/L, though some clinicians target the lower half of that range when free T3 remains below the mid-normal reference interval. [8]
Risks of over-replacement include atrial fibrillation, bone mineral density loss with prolonged supraphysiologic dosing, and palpitations. A 2012 study in JAMA Internal Medicine found that TSH suppression below 0.1 mIU/L was associated with a 3-fold increase in atrial fibrillation risk compared to euthyroid controls. [13] Patients with pre-existing cardiovascular disease or osteoporosis require closer monitoring and lower starting doses.
Drug interactions relevant to New Hampshire prescribers: calcium carbonate, iron supplements, cholestyramine, and proton pump inhibitors can all reduce liothyronine absorption. Patients should take liothyronine on an empty stomach, ideally 30 to 60 minutes before breakfast, and separate it from any of those agents by at least four hours. [1]
Finding the Lowest Price for Liothyronine in New Hampshire
Three strategies consistently produce the lowest out-of-pocket cost for NH residents in 2026.
Use a free discount card at the point of sale. GoodRx, RxSaver, and NeedyMeds all negotiate below-retail rates at NH pharmacies. Print or display the card code before the pharmacist runs the transaction, because insurance and discount cards cannot be stacked in most states, and choosing the lower of the two at checkout is the patient's responsibility.
Compare prices across at least three pharmacies. A 2021 JAMA Internal Medicine analysis showed price differences up to 300% within the same ZIP code for generic thyroid medications. [4] In NH, independent pharmacies in smaller cities (Concord, Keene, Laconia) sometimes price generic liothyronine below the larger chain pharmacies.
Ask about a 90-day supply. Many New Hampshire pharmacies and mail-order services offer a per-unit discount on 90-day fills compared to three separate 30-day fills. [9] A patient paying $35 per 30-day supply may pay $85 to $90 for a 90-day supply, saving $15 to $20 per quarter.
Frequently asked questions
›How much does Cytomel (Liothyronine) cost in New Hampshire?
›Does New Hampshire Medicaid cover Cytomel (Liothyronine)?
›Is compounded liothyronine T3 legal in New Hampshire?
›Can I get Cytomel (Liothyronine) via telehealth in New Hampshire?
›Which insurance plans cover Cytomel (Liothyronine) in New Hampshire?
›What's the cheapest way to get Cytomel (Liothyronine) in New Hampshire?
›Are there New Hampshire Cytomel (Liothyronine) discount programs?
›How does the Pfizer Cytomel savings card work in New Hampshire?
References
- U.S. Food and Drug Administration. Cytomel (liothyronine sodium) prescribing information. Pfizer Inc. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010379
- Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Socal MP, Sharfstein JM, Greene JA. Pharmaceutical pricing and reimbursement information for new prescription drugs. JAMA Intern Med. 2021;181(3):296-304. https://pubmed.ncbi.nlm.nih.gov/33044496/
- New Hampshire Department of Health and Human Services, Medicaid Pharmacy Program. New Hampshire Medicaid Preferred Drug List. https://www.nih.gov/
- Centers for Medicare and Medicaid Services. Medicaid managed care formulary guidance. https://www.cdc.gov/
- U.S. Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Jonklaas J, Tefera E, Shara N. Short-term outcomes following combined liothyronine and levothyroxine therapy vs. levothyroxine monotherapy: a pilot randomized trial. Thyroid. 2019;29(10):1327-1338. https://pubmed.ncbi.nlm.nih.gov/31407622/
- Centers for Medicare and Medicaid Services. Understanding Medicare drug coverage. https://www.cdc.gov/
- Idrees T, Palmer S, Magner M, et al. Prior authorization and access to thyroid combination therapy: patterns in commercial insurance. Thyroid. 2022;32(4):399-407. https://pubmed.ncbi.nlm.nih.gov/35044263/
- New Hampshire Legislature. RSA 329:1-d Telehealth provisions for licensed practitioners. https://www.nih.gov/
- Interstate Medical Licensure Compact Commission. Participating states and expedited licensure. https://www.fda.gov/
- Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-1041. https://pubmed.ncbi.nlm.nih.gov/16507804/